Non-selective beta-blockers control ascites and improve outcomes in cirrhotic patients with first episode of ascites

Key Points

• Ascites control improved with non-selective beta-blockers in cirrhotic patients.
• Liver function considerably enhanced in those treated with beta-blockers.
• Assessment involved cirrhotic patients experiencing their first episode of ascites over a defined period.
• Highlights the potential of beta-blockers for managing ascites in liver disease.